Pierre Singer
Corporate Officer/Principal bij Rabin Medical Center
Profiel
Pierre Singer is currently an Associate Professor at Tel-Aviv University and a Principal at Rabin Medical Center.
He previously worked as a Medical Director at High Tech Lipids Ltd.
Singer earned a doctorate degree from the University of Strasbourg.
Actieve functies van Pierre Singer
| Bedrijven | Functie | Begin |
|---|---|---|
| Rabin Medical Center | Corporate Officer/Principal | - |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | Corporate Officer/Principal | - |
Eerdere bekende functies van Pierre Singer
| Bedrijven | Functie | Einde |
|---|---|---|
High Tech Lipids Ltd.
 High Tech Lipids Ltd. Pharmaceuticals: MajorHealth Technology High Tech Lipids Ltd. develops lipid emulsions for infants and adults. It offers neonatal emulsions and immuno-nutrition lipids for chemotherapy patients, AIDS patients and other specific categories of surgical and critical care patients. The firm serves various sectors of the total parenteral nutrition (TPN) market, such as TPN manufacturers, healthcare providers and TPN patients. The company was founded by Geila Rozen and Irit Shochat in 2004 and is headquartered in D.N. Misgav, Israel. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Pierre Singer
| University of Strasbourg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
High Tech Lipids Ltd.
High Tech Lipids Ltd. Pharmaceuticals: MajorHealth Technology High Tech Lipids Ltd. develops lipid emulsions for infants and adults. It offers neonatal emulsions and immuno-nutrition lipids for chemotherapy patients, AIDS patients and other specific categories of surgical and critical care patients. The firm serves various sectors of the total parenteral nutrition (TPN) market, such as TPN manufacturers, healthcare providers and TPN patients. The company was founded by Geila Rozen and Irit Shochat in 2004 and is headquartered in D.N. Misgav, Israel. | Health Technology |
